2023
DOI: 10.1016/j.mycmed.2022.101356
|View full text |Cite
|
Sign up to set email alerts
|

Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Amphotericin B and fluconazole are used to treat T. asahii infections 45 , 46 . The hog1 gene-deficient mutants of C. neoformans and C. albicans are sensitive to an antifungal agent the amphotericin B (AMPH-B) 19 , 23 , 38 , 42 .…”
Section: Resultsmentioning
confidence: 99%
“…Amphotericin B and fluconazole are used to treat T. asahii infections 45 , 46 . The hog1 gene-deficient mutants of C. neoformans and C. albicans are sensitive to an antifungal agent the amphotericin B (AMPH-B) 19 , 23 , 38 , 42 .…”
Section: Resultsmentioning
confidence: 99%
“…However, in recent years, there have been increasing reports of azole resistance in clinical isolates of T. asahii and therapeutic failure after azole application. A number of clinical isolates have been found to be insensitive to fluconazole in in vitro drug sensitivity tests, resulting in a poor response to antifungal therapy in patients with invasive trichosporonosis [7,8].…”
Section: Introductionmentioning
confidence: 99%